Structural analysis of a natural apolipoprotein A-I variant (L60R) associated with amyloidosis.


Journal

Archives of biochemistry and biophysics
ISSN: 1096-0384
Titre abrégé: Arch Biochem Biophys
Pays: United States
ID NLM: 0372430

Informations de publication

Date de publication:
30 05 2020
Historique:
received: 26 10 2019
revised: 12 03 2020
accepted: 14 03 2020
pubmed: 21 3 2020
medline: 14 7 2020
entrez: 21 3 2020
Statut: ppublish

Résumé

The reason that determines the pathological deposition of human apolipoprotein A-I variants inducing organ failure has been under research since the early description of natural mutations in patients. To shed light into the events associated with protein aggregation, we studied the structural perturbations that may occur in the natural variant that shows a substitution of a Leucine by an Arginine in position 60 (L60R). Circular dichroism, intrinsic fluorescence measurements, and proteolysis analysis indicated that L60R was more unstable, more sensitive to cleavage and the N-terminus was more disorganized than the protein with the native sequence (Wt). A higher tendency to aggregate was also detected when L60R was incubated at physiological pH. In addition, the small structural rearrangement observed for the freshly folded variant led to the release of tumor necrosis factor-α and interleukin-1β from a model of macrophages. However, the mutant preserved both its dimeric conformation and its lipid-binding capacity. Our results strongly suggest that the chronic disease may be a consequence of the native conformation loss which elicits the release of protein conformations that could be either cytotoxic or precursors of amyloid conformations.

Identifiants

pubmed: 32194045
pii: S0003-9861(19)30965-8
doi: 10.1016/j.abb.2020.108347
pii:
doi:

Substances chimiques

Amyloidogenic Proteins 0
Apolipoprotein A-I 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108347

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of competing interest The authors declare that there are no competing interests associated with the manuscript.

Auteurs

Gisela M Gaddi (GM)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.

Romina A Gisonno (RA)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.

Silvana A Rosú (SA)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.

Lucrecia M Curto (LM)

Instituto de Química y Fisicoquímica Biológicas "Profesor Alejandro C. Paladini" (IQUIFIB) y Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CABA, Argentina.

Eduardo D Prieto (ED)

Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA) Universidad Nacional de La Plata-CONICET, La Plata, Buenos Aires, Argentina.

Guillermo R Schinella (GR)

Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina; Comisión de Investigaciones Científicas, Pcia de Buenos Aires, La Plata, Argentina.

Gabriela S Finarelli (GS)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina.

M Fernanda Cortez (MF)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina.

Letizia Bauzá (L)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina.

Esteban E Elías (EE)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina.

Nahuel A Ramella (NA)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina. Electronic address: nramella@med.unlp.edu.ar.

M Alejandra Tricerri (MA)

Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Calle 60 y 120. La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina. Electronic address: aletricerri@med.unlp.edu.ar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH